PARSIPPANY, N.J., July 7, 2011 /PRNewswire/ --JHP Pharmaceuticals, a leading provider of contract manufacturing services for sterile injectable products has entered into an agreement with an undisclosed pharmaceutical company. The agreement is for the product transfer and registration batch production of a life-saving drug.
Commenting on JHP’s selection, Stuart Hinchen, CEO and President of JHP noted, “Our cGMP compliance record and experienced staff allow us to effectively serve this important customer. JHP’s history of manufacturing DEA-regulated products is vital in producing this terminally sterilized life-saving drug. We see this partnership as another opportunity to demonstrate our customer-focused approach in the manufacture of quality-driven products that save patient lives.”
Hinchen also noted, “During the last six months, we successfully completed FDA and EMA audits in addition to entering agreements with four new contract customers. Our continued investment in our people and our facility has resulted in an internal infrastructure that supports ongoing sustainable growth.”
JHP’s Rochester, Michigan manufacturing site has a solid history of successful partnerships, manufacturing clinical and commercial products.
About JHP Pharmaceuticals, LLC
JHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile injectables and ophthalmic/otic products, for large and small pharmaceutical and biotech organizations.
JHP’s sterile manufacturing facility, located in Rochester Michigan sits on over 80 acres of land and includes a 171,000 sq. ft. production building and warehouse. The production facility utilizes three high-speed filling lines, a clinical filling line, four lyophilizers and an ophthalmic filling line. The site also includes separate facilities for chemistry, sterility testing, and analytical methods development.
JHP has the capability to manufacture small-scale clinical through large-scale commercial products. JHP employs more than 330 staff in the USA in its manufacturing, product development, sales & marketing and corporate areas. For more information, please visit www.jhppharma.com.
Contact:
Dan Leone
973.658.3559
Bill Conway
877.906.7556
SOURCE JHP Pharmaceuticals
